健康科学杂志

  • 国际标准期刊号: 1108-7366
  • 期刊 h 指数: 51
  • 期刊引用分数: 10.69
  • 期刊影响因子: 9.13
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • CINAHL 完整
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • EMCare
  • OCLC-WorldCat
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
分享此页面

抽象的

Human Papillomavirus and Cancer in Men

Chandrika Johnson, Nosa Obanor, Amanda DeWeese

Although human papillomavirus (HPV) issues have focused primarily on females, it is important to give attention to males because the primary mode of transmission of the virus is through sexual intercourse. There is increasing evidence that HPV is causing serious diseases like penile, anal, head, and neck cancer among males. Studies have also shown that, generally, males have similar rates of HPV infection (0.29 to 0.39 per 1000 person-month) as females. The vaccine against HPV, Gardasil®, has been used in women since 2006. In 2009, the FDA approved Gardasil® for men. Although questions about the efficacy of HPV vaccination in males remain, it is important to understand what males know about HPV and their predisposition towards being vaccinated against the virus.